The 1Q 23 numbers helps solidify Imdex's case that growth hasn't peaked yet. I have done a rough valuation and at current prices its at a 6.2 EV/EBITDA and 12.8 PE ratio. At 2.5 its 7.7 EV/EBITDA and 15.8 and at $3 its at 9.24 EV/EBITDA and 19 PE. There is definitely
support in the valuation for its growth back to $3.
1Q23 Results
- Forums
- ASX - By Stock
- IMD
- IMD Share Price Discussion
IMD Share Price Discussion, page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMD (ASX) to my watchlist
|
|||||
Last
$2.29 |
Change
-0.030(1.29%) |
Mkt cap ! $1.166B |
Open | High | Low | Value | Volume |
$2.28 | $2.31 | $2.27 | $537.1K | 233.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 7481 | $2.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.29 | 10479 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 7101 | 2.300 |
26 | 25928 | 2.290 |
16 | 23475 | 2.280 |
15 | 25775 | 2.270 |
6 | 3154 | 2.260 |
Price($) | Vol. | No. |
---|---|---|
2.310 | 14347 | 26 |
2.320 | 52663 | 29 |
2.330 | 24124 | 12 |
2.340 | 67378 | 9 |
2.350 | 27441 | 10 |
Last trade - 12.04pm 25/07/2024 (20 minute delay) ? |
Featured News
IMD (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online